Navigation Links
Free CME-certified Webcast: Making Your Case: Up-to-date Answers for Developing Trends in PCI
Date:10/19/2007

WASHINGTON, Oct. 19 /PRNewswire/ -- Interventional cardiologists operate in an environment of great flux, and as such face many challenges in the provision of optimal patient care. New devices, continuing debate over the use of drug-eluting versus bare metal stents, and evolving procedures involved in peripheral intervention are among these changes. Further, recently released ACC/AHA guidelines for the management of UA/NSTEMI patients, and soon-to-be released guidelines for the management of STEMI patients, issue revised recommendations concerning adjuvant pharmacotherapy for percutaneous coronary intervention (PCI) that will greatly impact clinical practice.

The free CME-certified Web cast, Making Your Case: Up-to-date Answers for Developing Trends in PCI aims to bridge the gap between evidence and patient care by assisting interventional cardiologists in translating guidelines into practice. The most recent evidence-based approaches for acute coronary syndrome (ACS) management will be presented by cardiology experts: C. Michael Gibson, MD; Ehtisham Mahmud, MD; Eric Peterson, MD, MPH; and Steven Steinhubl, MD. An interactive case-based discussion will follow and will highlight real world challenges and how to approach them.

The program will be presented on October 21, 2007, from 8:00 PM to 10:00 PM EDT. Broadcast live during the Transcatheter Cardiovascular Therapeutics annual meeting, this innovative, case-based symposium will provide interventional cardiologists and other clinicians with detailed information on treating patients with ACS. Those participating in the Web cast also have the opportunity to take part in the interactive ARS questions during the program. This activity is sponsored by INNOVIA Education Institute and supported by and educational grant from sanofi-aventis, U.S.

TITLE: Making Your Case: Up-to-date Answers for Developing Trends in PCI

FACULTY: C. Michael Gibson, MD; Ehtisham Mahmud, MD; Eric Peterson, MD,'/>"/>

SOURCE INNOVIA Education Institute, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. New Tools for Making and Processing Protein Microarrays.
2. Making deals with evolving technologies in mind
3. Fusion 2007: Making the business case for technology
4. Making the transition from Web 2.0 to Web 2.007
5. 9 tips for making 90 seconds count in an investment pitch
6. Making sure YourSpace is technologically sound
7. Making Wisconsin the biotechnology leader
8. Mirus announces new method for making antibodies
9. Fusion 2006 symposium focuses on making IT work for businesses
10. Making RFID mainstream
11. Four steps to making talent management a core competence

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...SPRINGFIELD, Ill., Dec. 1 Prairie ...nounce that it was recently awarded two statuettes... Nov. 13 in New York City. The CLIO Healthcare Awa...in the healthcare advertising industry and is an e...st recognized awards competitions for advertising,...
(Date:12/1/2009)... EpiVax, Inc. today announced a collabor... OTCQX: RHHBY) aimed at evaluating EpiVax’s ...ntially reduce detrimental immune responses to cer...aboration, the EpiVax Tregitope technology will be...of protein therapeutics. , ...
(Date:12/1/2009)... , SAN DIEGO, Dec. 1 ...nnounced today that it will present at the LD MICR... p.m. (PST) at the Luxe Hotel in Los Angeles. Aeth...ll present a corporate overview and will provide a...s lead product, the Hemopurifier®, a first-in...
(Date:12/1/2009)..., HARBIN, China, Dec. 1 /PRNewswire-Asia-Fi...y One Medical" or "the Company") (Nasdaq: CSKI ),... developing and producing,over-the-counter drugs i...nounced that the Company has engaged Guangdong Med... ("MDK") to serve as its exclusive sales agent for...
Breaking Biology Technology:Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3
... Calif., Oct. 29 Sangamo,BioSciences, Inc. (Nasda...cial results and accomplishments., For the third ... a,consolidated net loss of $6.3 million, or $0.15..., or $0.11 per share, for the same period in 2007....ash equivalents and,investments of $59.5 million. ...
...Mass., Oct. 29 Aware, Inc. (Nasdaq:,AWRE), a lead...s software,announced today that its Board of Direc...inally authorized on August 28, 2007 to repurchase...o $5 million worth of shares of,the Company,s comm...cember,31, 2009 at prevailing market prices. The B...
...lion Net Revenues, $0.10 Net Income Per Share, SA...ies, Inc. (Nasdaq: VNUS ), a leading provider of ...nt of venous disease, today announced its,financia..., 2008., Net revenues for the third quarter of 20...7.5 million for the third quarter of 2007. Net,rev...
Other Biology Technology:Sangamo BioSciences Reports Third Quarter 2008 Financial Results 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 3Sangamo BioSciences Reports Third Quarter 2008 Financial Results 4Sangamo BioSciences Reports Third Quarter 2008 Financial Results 5Sangamo BioSciences Reports Third Quarter 2008 Financial Results 6Sangamo BioSciences Reports Third Quarter 2008 Financial Results 7Aware, Inc. Announces Extension of Stock Repurchase Plan 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 3VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 4VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 5VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 6VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 7VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 8VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 9VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 10
(Date:11/30/2009)...pings of gravy and dessert at the holiday table ar...ously thought. According to a new research report ... http://www.fasebj.org ), a diet that is high in f...timately cause our bodies to store too much fat. T... as the already difficult task of converting high-...
(Date:11/30/2009)...s available in German . , The DFG has appro...arch Centres as of 1 January 2010. This decision w...in Bonn. The new centres will initially be funded ...ition, 20 percent overhead funding for indirect co...ntres, research topics range from modern prosthese...
(Date:11/30/2009)...- The inaugural Global Conference on Systems & Ent... Washington, DC, focuses on the convergence of com...al importance to society. , The goal of the ...ivity around targeted complex systems, examined by...includes Critical Infrastructure Systems, includin...
Breaking Biology News(10 mins):Happy holidays from the groaning board; Western diets turn on fat genes 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Finesse Solutions Expands Into State of the Art Facility in San Jose CA USA 12606 1Aussie and Kiwi researchers make double MS genetic discovery 8821 1Aussie and Kiwi researchers make double MS genetic discovery 8821 2Symbia net Hotspot for Remote Access 48825 1Symbia net Hotspot for Remote Access 48825 2Symbia net Hotspot for Remote Access 48825 3
...sts from around the world will convene at the Univ... key findings from the most ambitious effort ever ...tants in the Arctic and determine how they contrib...way in the vast, climate-sensitive region. , The ...ARCAT was conducted most intensively during two th...
...ands, May 26, 2009 There are several risk factors...scular dementia. Based on an increasing number of ...deficiency, an article in the current issue of the...lliam B. Grant, PhD of the Sunlight, Nutrition, an...rther investigation of possible direct or indirect...
...sen sharply in developed countries in the wake of ...Europeans live with the condition. Foot problems a...for diabetics, who are at risk of serious complica...lood supply to their feet. Both conditions can lea... they get infected and become gangrenous, can lead...
Other Biology News:Spring agricultural fires have large impact on melting Arctic 2Spring agricultural fires have large impact on melting Arctic 3Is vitamin D deficiency linked to Alzheimer's disease and vascular dementia? 2Protective footwear for diabetics at a high-street price 2Protective footwear for diabetics at a high-street price 3
Amido Black 10B, CI 20470 from Research Organics, Inc.
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from GeneTex
Anti-Human Ig Lambda-chain Monoclonal Antibody, Unconjugated, Clone ICO-16 from Cell Sciences
Biology Products: